跳至主要内容
临床试验/CTRI/2025/06/088264
CTRI/2025/06/088264尚未招募2/3 期

A Randomized comparative clinical trial to evaluate the efficacy of Integrated and Ayurvedicprotocol in achieving Sukhaprasava.

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月12日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Sukhaprasava (Normal Vaginal Delivery)

研究概览

简要总结

Need of Study: To decrease the utilization of oxytocic drugs in conduction of normal vaginal delivery. Protracted cervical dilatation and unripe cervix are the leading causes of fetal distress and prolonged labor. Yoni Pichu application during 9th month brings optimum effacement and ripening of cervix as it causes hydration of tissues and remodeling of cervix. Basti and Yoni Pichu increases uterine tone and avoid atonic PPH and reduce the rate of obstetric hysterectomy due to PPH. Null Hypothesis: There is no difference between Integrated and Ayurvedic protocol in achieving Sukhaprasava Alternate hypothesis. There is difference between Integrated and Ayurvedic protocol in achieving

Sukhaprasava

Research Question: Is there any difference between Integrated and Ayurvedic protocol in achieving Sukhaprasava? Aim: To evaluate and compare the efficacy of Integrated and Ayurvedic protocol in achieving Sukhaprasava. Primary Objective: To evaluate and compare the efficacy of integrated and Ayurvedic protocol in achieving Sukhaprasava. Secondary Objective: To access and compare the incidence of complications of all the four stages of labor and up to 10 days after delivery. To access and compare the rate of Sukhaprasava (Eutocia) and Shalyajanana (Caesarean section) To access and compare the incidence of fetal distress. Drug Intervention: Two Group Group MBP- Bala Taila Matra basti, Kebuka Tala Yoni Pichu. Asthapan Basti with Erand Taila and Dashmool Kwath, Tab Misoprostol Group BP- Bala Taila Matra basti, Kebuka Talla Yoni Pichu, Asthapan Basti with Erand Taila and Dashmool Kwath.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Patient with 37th week of gestation with singleton pregnancy & cephalic presentation Patient between age of 21 to 40 years Height.
  • 4feet 10inch to 5feet 8inch (148 to 172cm) Hemoglobin more than or equal to 10gm percentage Patient with borderline or adequate pelvis.

排除标准

  • History of previous LSCS Patient having Bad obstetric history, precious pregnancy Pregnancy associated with severe Pregnancy induced hypertension, Pre-eclampsia, Eclampsia, Gestational Diabetes, Placenta previa, Abruptio placentae, severe oligohydramnios, severe polyhydramnios, severe IUGR Patients with Cephalo-pelvic disproportion, malpresentation.
  • Patients suffering with systemic disorders like Diabetes Mellitus, Renal dysfunction, Cardiac disorder, Tuberculosis, Coagulopathies.
  • Patients diagnosed with Benign or Malignant tumor of Reproductive system, Recto vaginal fistula, Vesico-vaginal fistula, second and third degree uterine prolapse History of Fothergill repair, Recto vaginal fistula, Vesico-vaginal fistula VDRL, HIV, HBsAg positive pregnant woman.

结局指标

主要结局

Sukhaprasava (Normal Vaginal Delivery)

时间窗: 45 days

次要结局

  • •Difference in the incidence of complications of all four stages of labor and up to 10 days postpartum between the groups.(•Difference in the rate of Sukhaprasava (Eutocia) & Shalyajanana (Caesarean section) between the groups)

研究者

申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验